SlideShare ist ein Scribd-Unternehmen logo
1 von 32
Joint Working Workshop
The “7 Step framework”
Sharing best practice
Identifying opportunities using real world data
Kevin Blakemore, National Partnership Manager| ABPI
Helen Wheeler, National Project Manager | Sanofi
Hassan Chaudhury, Director of Health Intelligence | Health iQ
Our common goal
Win:Win:Win:Win:Win
Public
NHS
Academia
Voluntary
Sector
Industry
Social
Care
Quick Start Guide – May 2012
Flow Chart
Promotion Joint
Working
MEGS Sponsorship
For patient benefit
Yes Yes Yes Yes
NHS/Pharma company pool resources
X Yes X X
Pharma company investment
Yes Yes Yes Yes
NHS investment
X Yes X O
Detailed agreement in place
X Yes X X
Shared commitment to successful
delivery
X Yes Yes Yes
Details of the agreement are made
public
X Yes O X
Prospective ROI Yes Yes X X
Outcomes must be measured
X Yes O X
The Charles Town Project-
Having the confidence to share
gives us confidence to learn
Helen Wheeler, National Project Manager | Sanofi
Original Proposal
•Aim was to form a collaborative group to undertake a programme of
activities developed to address the health issues around Diabetes
•To be known collectively as the “NHS Charles Town and Industry
Maximising Resources and Outcomes in Diabetes (Concord )”project
Goals
•To ensure delivery of high quality diabetes care
•To reduce diabetes health inequalities
•Improve outcomes for all patients with diabetes in Charles Town regardless
of where they live.
Objectives of the Project
1) To reduce the rate / number of avoidable admissions to hospital for patients with diabetes
and diabetes related illness.
2) To reduce the rate of inappropriate / avoidable utilisation of emergency services for people
with diabetes related illnesses.
3) To develop and implement a coherent care planning approach to the management of
people with diabetes across primary, secondary and community services, which ensures
that all patients have the opportunity to be actively involved in decisions about how their
diabetes is managed.
4) To work in partnership with all stakeholders including the pharmaceutical industry, in an
innovative and inclusive way throughout the project to achieve outcomes which benefit
patients with diabetes in Charles Town
5) To ensure that all activities are developed and implemented in a way which improves the
quality, efficiency and cost effectiveness of care in line with national QIPP objectives.
Primary Care
Clinician
/Secondary Care
Clinician
Primary Care
Nurse
(with diabetes
expertise)
Community
Pharmacy/PBC
cluster
managers and
clinical leads
Charles Town
“City Health”
(provider arm)
/NHS Charles
Town Health
promotion
NHS Charles Town
Public Health/ NHS
Charles Town Clinical
Audit/ NHS Charles
Town Commissioning
Directorate
Pharmaceutical
Industry
(one seat per
organisation)
NHS Charles
Town Primary
Care Contracting/
NHS Charles
Town Medicines
Management
+ 8 industry partners
Patient
Representative
Developed and managed in partnership with the ABPI Outreach Project who formed a group of
interested member companies to act as equal stakeholders throughout.
PCT-led project managed by a multi-professional multi-agency steering group consisting of a
lead from each of the following stakeholder groups:
Project Methodology
In a Nutshell
• In-Patient Audit commissioned by the LOCAL IMPLEMENTATION GROUP
• Driven through a PROJECT GROUP
• Managed by a highly experienced independent PROJECT MANAGER paid by the
Project sponsors through the budget.
Different stakeholders theoretically agreed with the project aims and rationale
Equity of industry and NHS
Endorsement of the Project from a high level (Chief Executive)
Collaborative concept was good
Excellent launch - with motivational and national figures in support
Innovation project based upon a well established and successful project that the Project
Manager had led previously
In theory should have just replicated the last CHD project
PM was a third party and theoretically objective and skilled
What worked well
Became a duel
between commissioning
lead/clinical leads and
project lead
Scepticism between
NHS and industry had
not left the room
Industry was diluted -
too many partners
Skill set in the project
team not utilised
Industry had much
of the data that
was needed
Level of investment did
not = level of voice
Project lead became a
facilitator between
Industry & NHS - should
have been left behind
once partnership
agreed
Poor dynamics
Too controlled and
inhibited freedom of
speech
Declaration of interest
to other industry outside
of the group
Did the Project team
fully understand the
therapy area?
No clear timelines
What did not go so well
What went wrong: key
Communication
between
Stakeholders
No real Equity of
Voice
Outcomes
Questions were asked around:
– Freedom of entry - became a closed shop
– Competition Law
– Lack of transparency due to communication between the PM and the LIG
– Industry skill set not maximised/ Project Management experience
– Loss of confidence by the LIG
– LIG pulled out money - returned to industry
What needs to happen
– The Patient must be at the centre of all this otherwise what is it all about?
– Old ways need to be left behind – innovation
trust need to be our future
honesty
– Some one needs to step up and say:
“Is this project going to lead to better Health outcomes for the Patient?”
if the answer is yes
“Have we as potential partners got the right resource and capacity together to drive this
through”?
if the answer is yes
“well let‟s just get on with it”
Where are we now?
• LIG still see the Value in the Project
• DUK still see value in the project
• Industry has much of the data that is needed as well as the skill set and capacity to project
manage
• Access still difficult between Secondary Care and Industry
• SC still very dominant and protective - this needs to change
• Patients still in the same place and could be better serviced- no body won and the war keeps
raging
Ensure a mechanism for genuine input
Use a more effective channel of communication to the LIG
Improve the equity of voice - but perhaps less voices??
Have clear terms of references
Better governance
Make a safe environment for all stakeholders to give an honest declaration of interest
- what do you want out of the project?
- how as a company are you going to measure success?
Ensure that the project is not dominated
Identify and utilise what you already have before buying more
Trust - do not move forward without this
How would we do this differently?
Any Questions?
Group Work
1. How could some of these issues have been avoided? Refer to hand-out
2. How could the “7 Step framework” have been used?
3. Have you participated in a joint working project that was unsuccessful?
a. why was it unsuccessful?
b. what did you learn from it?
4. Of the 9 indicators for joint working, which are top 3 most important and why?
a. Are there any other indicators that should be included ?
Knowledge & Expertise
Trust
Ethics
Project management
Transparency
Openness
Respect
Effectiveness
Support
Identifying Joint Working
Opportunities-
7d
Using real world data
Hassan Chaudhury, Director of Health Intelligence | Health iQ
CCG Data
Quick Facts:
– Not in London (somewhere in the Midlands)
– Ethnically diverse.
– Population of 600,000 - which is rapidly rising.
– Over 50 GP Practices.
– Higher than average deprivation.
– Lower than average life expectancy with a lot of variation across the CCG.
– Prescribing costs have gone up faster than expected as have emergency
admissions.
– Mental health costs are very high.
• It has had discussions on choosing its 3 local measures for the Quality Premium
(c.f. http://www.england.nhs.uk/wp-content/uploads/2013/05/qual-premium.pdf)
What is the Quality Premium?
Four Areas to explain:
1.The „quality premium‟ is intended to reward clinical commissioning groups
(CCGs) for improvements in the quality of the services that they commission and
for associated improvements in health outcomes and reducing inequalities.
2.The quality premium paid to CCGs in 2014/15 – to reflect the quality of the
health services commissioned by them in 2013/14 – will be based on:
four national measures and three local measures.
What is the Quality Premium?
3. The four national measures, all of which are based on measures in the NHS
Outcomes Framework, are:
1) reducing potential years of lives lost through amenable mortality (12.5 per cent of
quality premium): the overarching objective for Domain 1 of the NHS Outcomes
Framework;
2) reducing avoidable emergency admissions (25 per cent of quality premium): a
composite measure drawn from four measures in Domains 2 and 3 of the NHS
Outcomes Framework;
3) ensuring roll-out of the Friends and Family Test and improving patient experience
of hospital services (12.5 per cent of quality premium), based on one of the
overarching objectives for Domain 4 of the NHS Outcomes Framework
4) preventing healthcare associated infections (12.5 per cent of quality premium),
based on one of the objectives for Domain 5 of the NHS Outcomes Framework.
What is the Quality Premium?
4. The three local measures should be based on local priorities such as those
identified in joint health and wellbeing strategies.
These will be agreed by individual CCGs with their Health and Wellbeing Boards
and with the area teams of the NHS Commissioning Board (NHS CB).
What they select must also be in line with other local priorities e.g.:
- Improved Outcomes
- High Quality Care
- Tackle unwarranted variation and strengthen out of hospital care
- Efficient and effective care pathways
- Development of integrated multi agency care pathways
What is the Quality Premium?
It was decided that the three local measures would be selected to also help achieve
the four national measures. The most significant of the national measures is on
emergency admissions (25% of the total).
- Last year there were over 56,000 emergency admissions of local residents.
- Giving a rate of 75 admissions per 1,000 people.
- Of these admissions over 25,400 (44%) are repeat emergency admissions.
- Over a half of all emergency admissions arrive via the hospital‟s A&E department.
- Nearly a third of admissions arrive from a General Practitioner (GP)
These two methods account for nearly 90% of all emergency admissions.
- The total cost of all emergency admissions by local
residents exceeded £90 million.
Group Work
Look at the following data on emergency admissions and decide: what
does the data demonstrate?
Can you use this information to select areas for your local measure or is
further information required?
If so, which areas would you want to focus on and what you would want to
achieve?
15 Minutes
Local Measures
The 3 areas they chose were CHD, COPD and Diabetes.
ACSC emergency admissions in the CCG now make up 14.1% of all emergency
hospital admissions, at a current cost of around £13 million annually.
This is what they wanted to achieve:
1. Increasing the number of patients with coronary heart disease who completed
cardiac rehabilitation.
2. Increasing the number of people with COPD referred to a pulmonary
rehabilitation programme.
3. Increasing the number of people with diabetes diagnosed less than a year
being referred to structured education.
Let’s focus on diabetes…
• What Joint Working opportunities can you think of?
• How can parties work together for the benefit of patients, industry and the NHS?
• How would you utilise the 7 step framework?
• Would you help with setting up a Diabetes Multidisciplinary Team (NDMT)
i.e. a group of specialist nurses, podiatrists, dieticians, diabetologists, and
multi-skilled practitioners: all dedicated to improving the quality of care and providing
people with diabetes with the training needed to help them self-manage
• Would you help with data?
• Patient support? Perhaps help to map pathways.
The choice is yours 15 Minutes
Closing Remarks7d
Outcomes and Feedback
Karen Thomas, Regional Partnership Manager London | ABPI
What do you see?
Working in Partnership
To achieve…….
“ High quality care for all, for now and for
the future generations”
NHS England

Weitere ähnliche Inhalte

Was ist angesagt?

East Midlands Academic Health Science Network – igniting innovation Dr Carl...
East Midlands Academic Health Science Network – igniting innovation   Dr Carl...East Midlands Academic Health Science Network – igniting innovation   Dr Carl...
East Midlands Academic Health Science Network – igniting innovation Dr Carl...
PM Society
 
Joint working the CRN perspective Professor Oleg Eremin
Joint working the CRN perspective   Professor Oleg EreminJoint working the CRN perspective   Professor Oleg Eremin
Joint working the CRN perspective Professor Oleg Eremin
PM Society
 
Joint working varied success!
Joint working   varied success!Joint working   varied success!
Joint working varied success!
PM Society
 
Joint working the 7 step framework
Joint working the 7 step frameworkJoint working the 7 step framework
Joint working the 7 step framework
PM Society
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
PM Society
 
Action Plan for Health Research
Action Plan for Health ResearchAction Plan for Health Research
Action Plan for Health Research
breslinj
 

Was ist angesagt? (20)

East Midlands Academic Health Science Network – igniting innovation Dr Carl...
East Midlands Academic Health Science Network – igniting innovation   Dr Carl...East Midlands Academic Health Science Network – igniting innovation   Dr Carl...
East Midlands Academic Health Science Network – igniting innovation Dr Carl...
 
Quality improvement, using NICE tools and resources
Quality improvement, using NICE tools and resourcesQuality improvement, using NICE tools and resources
Quality improvement, using NICE tools and resources
 
Joint working the CRN perspective Professor Oleg Eremin
Joint working the CRN perspective   Professor Oleg EreminJoint working the CRN perspective   Professor Oleg Eremin
Joint working the CRN perspective Professor Oleg Eremin
 
Joint working varied success!
Joint working   varied success!Joint working   varied success!
Joint working varied success!
 
Keynote address - Secretary of State for Health Jeremy Hunt
Keynote address - Secretary of State for Health Jeremy HuntKeynote address - Secretary of State for Health Jeremy Hunt
Keynote address - Secretary of State for Health Jeremy Hunt
 
Responding to Non COVID-19: Identification of deterioration in children
Responding to Non COVID-19: Identification of deterioration in childrenResponding to Non COVID-19: Identification of deterioration in children
Responding to Non COVID-19: Identification of deterioration in children
 
Joint working the 7 step framework
Joint working the 7 step frameworkJoint working the 7 step framework
Joint working the 7 step framework
 
Driving progress in healthcare through NHS research
Driving progress in healthcare through NHS researchDriving progress in healthcare through NHS research
Driving progress in healthcare through NHS research
 
Pharmacy working together to put Lord Carter’s recommendations into practice
Pharmacy working together to put Lord Carter’s recommendations into practicePharmacy working together to put Lord Carter’s recommendations into practice
Pharmacy working together to put Lord Carter’s recommendations into practice
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
 
Darren Clark (Medilinks) Healthcare scientists partnerships with industry h...
Darren Clark (Medilinks)   Healthcare scientists partnerships with industry h...Darren Clark (Medilinks)   Healthcare scientists partnerships with industry h...
Darren Clark (Medilinks) Healthcare scientists partnerships with industry h...
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
 
Action Plan for Health Research
Action Plan for Health ResearchAction Plan for Health Research
Action Plan for Health Research
 
The Role of Health Research Wales in supporting Industry Research in Betsi Ca...
The Role of Health Research Wales in supporting Industry Research in Betsi Ca...The Role of Health Research Wales in supporting Industry Research in Betsi Ca...
The Role of Health Research Wales in supporting Industry Research in Betsi Ca...
 
Developing Effective Remote Consultations in Outpatients webinar
Developing Effective Remote Consultations in Outpatients webinarDeveloping Effective Remote Consultations in Outpatients webinar
Developing Effective Remote Consultations in Outpatients webinar
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSI
 
Data-driven population health
Data-driven population healthData-driven population health
Data-driven population health
 
James Downie
James DownieJames Downie
James Downie
 
Day 1: Challenges and opportunities for better detection, diagnosis and clini...
Day 1: Challenges and opportunities for better detection, diagnosis and clini...Day 1: Challenges and opportunities for better detection, diagnosis and clini...
Day 1: Challenges and opportunities for better detection, diagnosis and clini...
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 

Ähnlich wie Joint Working workshop

ABPI and our regional industry groups
ABPI and our regional industry groupsABPI and our regional industry groups
ABPI and our regional industry groups
PM Society
 
ABPI joint working workshop
ABPI joint working workshopABPI joint working workshop
ABPI joint working workshop
PM Society
 
Workshop 3: Overview
Workshop 3: OverviewWorkshop 3: Overview
Workshop 3: Overview
aaltunalboro
 
Joan Saddler: Implications for putting patients and the public first
Joan Saddler: Implications for putting patients and the public firstJoan Saddler: Implications for putting patients and the public first
Joan Saddler: Implications for putting patients and the public first
Nuffield Trust
 
150408 Posters for Evidence Live
150408 Posters for Evidence Live150408 Posters for Evidence Live
150408 Posters for Evidence Live
Alison Turner
 
Networks in health overview presentation 1st aug 2013
Networks in health overview presentation 1st aug 2013Networks in health overview presentation 1st aug 2013
Networks in health overview presentation 1st aug 2013
Alexandra Merckx
 
Behavioral Health Specialist Meeting: Keeping You in the Loop
Behavioral Health Specialist Meeting: Keeping You in the LoopBehavioral Health Specialist Meeting: Keeping You in the Loop
Behavioral Health Specialist Meeting: Keeping You in the Loop
mednetone
 

Ähnlich wie Joint Working workshop (20)

How Hepatitis Outcomes Are Being Improved Via Modern Communication Methods - ...
How Hepatitis Outcomes Are Being Improved Via Modern Communication Methods - ...How Hepatitis Outcomes Are Being Improved Via Modern Communication Methods - ...
How Hepatitis Outcomes Are Being Improved Via Modern Communication Methods - ...
 
ABPI and our regional industry groups
ABPI and our regional industry groupsABPI and our regional industry groups
ABPI and our regional industry groups
 
ABPI joint working workshop
ABPI joint working workshopABPI joint working workshop
ABPI joint working workshop
 
Stratified Medicines Innovation Platform
Stratified Medicines Innovation PlatformStratified Medicines Innovation Platform
Stratified Medicines Innovation Platform
 
Oldham Health Commission
Oldham Health CommissionOldham Health Commission
Oldham Health Commission
 
Workshop 3: Overview
Workshop 3: OverviewWorkshop 3: Overview
Workshop 3: Overview
 
Making our practice open and transparent: the potential of electronic data ca...
Making our practice open and transparent: the potential of electronic data ca...Making our practice open and transparent: the potential of electronic data ca...
Making our practice open and transparent: the potential of electronic data ca...
 
Joan Saddler: Implications for putting patients and the public first
Joan Saddler: Implications for putting patients and the public firstJoan Saddler: Implications for putting patients and the public first
Joan Saddler: Implications for putting patients and the public first
 
150408 Posters for Evidence Live
150408 Posters for Evidence Live150408 Posters for Evidence Live
150408 Posters for Evidence Live
 
Triple Aim Design Thinking - Stanford MedX 2014
Triple Aim Design Thinking - Stanford MedX 2014Triple Aim Design Thinking - Stanford MedX 2014
Triple Aim Design Thinking - Stanford MedX 2014
 
Quality improvement theory and practice in healthcare
Quality improvement theory and practice in healthcareQuality improvement theory and practice in healthcare
Quality improvement theory and practice in healthcare
 
Lean thinking for the nhs
Lean thinking for the nhsLean thinking for the nhs
Lean thinking for the nhs
 
Healthcare transition in GCC: Current Painful Realities & Proposed Strategic ...
Healthcare transition in GCC: Current Painful Realities & Proposed Strategic ...Healthcare transition in GCC: Current Painful Realities & Proposed Strategic ...
Healthcare transition in GCC: Current Painful Realities & Proposed Strategic ...
 
eHealth Ecosystem - Dr Derick Mitchell - October 2017
eHealth Ecosystem - Dr Derick Mitchell - October 2017eHealth Ecosystem - Dr Derick Mitchell - October 2017
eHealth Ecosystem - Dr Derick Mitchell - October 2017
 
AVAwareness
AVAwarenessAVAwareness
AVAwareness
 
Networks in health overview presentation 1st aug 2013
Networks in health overview presentation 1st aug 2013Networks in health overview presentation 1st aug 2013
Networks in health overview presentation 1st aug 2013
 
Excel in Health: Understanding the NHS Landscape
Excel in Health: Understanding the NHS LandscapeExcel in Health: Understanding the NHS Landscape
Excel in Health: Understanding the NHS Landscape
 
Ccih2019 collaboration-in-health-systems-campbell
Ccih2019 collaboration-in-health-systems-campbellCcih2019 collaboration-in-health-systems-campbell
Ccih2019 collaboration-in-health-systems-campbell
 
Behavioral Health Specialist Meeting: Keeping You in the Loop
Behavioral Health Specialist Meeting: Keeping You in the LoopBehavioral Health Specialist Meeting: Keeping You in the Loop
Behavioral Health Specialist Meeting: Keeping You in the Loop
 
Canada’s innovation agenda apr 13, 2017
Canada’s innovation agenda apr 13, 2017Canada’s innovation agenda apr 13, 2017
Canada’s innovation agenda apr 13, 2017
 

Mehr von PM Society

Executive's Sleepless NIghts - Can Drugs Help?
Executive's Sleepless NIghts - Can Drugs Help?Executive's Sleepless NIghts - Can Drugs Help?
Executive's Sleepless NIghts - Can Drugs Help?
PM Society
 
Industry and the NHS - survey results
Industry and the NHS - survey resultsIndustry and the NHS - survey results
Industry and the NHS - survey results
PM Society
 
Industry and the NHS - survey results
Industry and the NHS - survey resultsIndustry and the NHS - survey results
Industry and the NHS - survey results
PM Society
 
Can Promotion and Partnership Coexist?
Can Promotion and Partnership Coexist?Can Promotion and Partnership Coexist?
Can Promotion and Partnership Coexist?
PM Society
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
PM Society
 
The NHS’ vision for medicines optimisation - the role for pharma in driving ...
The NHS’ vision for medicines optimisation -  the role for pharma in driving ...The NHS’ vision for medicines optimisation -  the role for pharma in driving ...
The NHS’ vision for medicines optimisation - the role for pharma in driving ...
PM Society
 
Supporting medicines adherence developing the pharmacist contribution
Supporting medicines adherence   developing the pharmacist contributionSupporting medicines adherence   developing the pharmacist contribution
Supporting medicines adherence developing the pharmacist contribution
PM Society
 
Patient adherence – what’s the problem?
Patient adherence – what’s the problem?Patient adherence – what’s the problem?
Patient adherence – what’s the problem?
PM Society
 
The way forward for greater manchester academic health science network ahsn
The way forward for greater manchester academic health science network ahsnThe way forward for greater manchester academic health science network ahsn
The way forward for greater manchester academic health science network ahsn
PM Society
 
So what is medicines optimisation
So what is medicines optimisationSo what is medicines optimisation
So what is medicines optimisation
PM Society
 
Joint working the 7 step framework
Joint working the 7 step frameworkJoint working the 7 step framework
Joint working the 7 step framework
PM Society
 
Moving forward with the greater manchester formulary
Moving forward with the greater manchester formularyMoving forward with the greater manchester formulary
Moving forward with the greater manchester formulary
PM Society
 
Joint working varied success!
Joint working   varied success!Joint working   varied success!
Joint working varied success!
PM Society
 
Engagement within the new system
Engagement within the new systemEngagement within the new system
Engagement within the new system
PM Society
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
PM Society
 
A vision for cheshire and mersey clrn
A vision for cheshire and mersey clrnA vision for cheshire and mersey clrn
A vision for cheshire and mersey clrn
PM Society
 
So what is medicines optimisation
So what is medicines optimisationSo what is medicines optimisation
So what is medicines optimisation
PM Society
 
ABPI and our Regional Industry Groups Stephen Fensome
ABPI and our Regional Industry Groups Stephen FensomeABPI and our Regional Industry Groups Stephen Fensome
ABPI and our Regional Industry Groups Stephen Fensome
PM Society
 
Abpi and our regional industry groups karen thomas
Abpi and our regional industry groups karen thomasAbpi and our regional industry groups karen thomas
Abpi and our regional industry groups karen thomas
PM Society
 

Mehr von PM Society (19)

Executive's Sleepless NIghts - Can Drugs Help?
Executive's Sleepless NIghts - Can Drugs Help?Executive's Sleepless NIghts - Can Drugs Help?
Executive's Sleepless NIghts - Can Drugs Help?
 
Industry and the NHS - survey results
Industry and the NHS - survey resultsIndustry and the NHS - survey results
Industry and the NHS - survey results
 
Industry and the NHS - survey results
Industry and the NHS - survey resultsIndustry and the NHS - survey results
Industry and the NHS - survey results
 
Can Promotion and Partnership Coexist?
Can Promotion and Partnership Coexist?Can Promotion and Partnership Coexist?
Can Promotion and Partnership Coexist?
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
 
The NHS’ vision for medicines optimisation - the role for pharma in driving ...
The NHS’ vision for medicines optimisation -  the role for pharma in driving ...The NHS’ vision for medicines optimisation -  the role for pharma in driving ...
The NHS’ vision for medicines optimisation - the role for pharma in driving ...
 
Supporting medicines adherence developing the pharmacist contribution
Supporting medicines adherence   developing the pharmacist contributionSupporting medicines adherence   developing the pharmacist contribution
Supporting medicines adherence developing the pharmacist contribution
 
Patient adherence – what’s the problem?
Patient adherence – what’s the problem?Patient adherence – what’s the problem?
Patient adherence – what’s the problem?
 
The way forward for greater manchester academic health science network ahsn
The way forward for greater manchester academic health science network ahsnThe way forward for greater manchester academic health science network ahsn
The way forward for greater manchester academic health science network ahsn
 
So what is medicines optimisation
So what is medicines optimisationSo what is medicines optimisation
So what is medicines optimisation
 
Joint working the 7 step framework
Joint working the 7 step frameworkJoint working the 7 step framework
Joint working the 7 step framework
 
Moving forward with the greater manchester formulary
Moving forward with the greater manchester formularyMoving forward with the greater manchester formulary
Moving forward with the greater manchester formulary
 
Joint working varied success!
Joint working   varied success!Joint working   varied success!
Joint working varied success!
 
Engagement within the new system
Engagement within the new systemEngagement within the new system
Engagement within the new system
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
 
A vision for cheshire and mersey clrn
A vision for cheshire and mersey clrnA vision for cheshire and mersey clrn
A vision for cheshire and mersey clrn
 
So what is medicines optimisation
So what is medicines optimisationSo what is medicines optimisation
So what is medicines optimisation
 
ABPI and our Regional Industry Groups Stephen Fensome
ABPI and our Regional Industry Groups Stephen FensomeABPI and our Regional Industry Groups Stephen Fensome
ABPI and our Regional Industry Groups Stephen Fensome
 
Abpi and our regional industry groups karen thomas
Abpi and our regional industry groups karen thomasAbpi and our regional industry groups karen thomas
Abpi and our regional industry groups karen thomas
 

Kürzlich hochgeladen

Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
amitlee9823
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Abortion pills in Kuwait Cytotec pills in Kuwait
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
Abortion pills in Kuwait Cytotec pills in Kuwait
 
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
Renandantas16
 

Kürzlich hochgeladen (20)

Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
 
Call Girls In Panjim North Goa 9971646499 Genuine Service
Call Girls In Panjim North Goa 9971646499 Genuine ServiceCall Girls In Panjim North Goa 9971646499 Genuine Service
Call Girls In Panjim North Goa 9971646499 Genuine Service
 
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
 
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLMONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
 
Pharma Works Profile of Karan Communications
Pharma Works Profile of Karan CommunicationsPharma Works Profile of Karan Communications
Pharma Works Profile of Karan Communications
 
Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with Culture
 
Mondelez State of Snacking and Future Trends 2023
Mondelez State of Snacking and Future Trends 2023Mondelez State of Snacking and Future Trends 2023
Mondelez State of Snacking and Future Trends 2023
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Forklift Operations: Safety through Cartoons
Forklift Operations: Safety through CartoonsForklift Operations: Safety through Cartoons
Forklift Operations: Safety through Cartoons
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Century
 
A DAY IN THE LIFE OF A SALESMAN / WOMAN
A DAY IN THE LIFE OF A  SALESMAN / WOMANA DAY IN THE LIFE OF A  SALESMAN / WOMAN
A DAY IN THE LIFE OF A SALESMAN / WOMAN
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League City
 
Grateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdfGrateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdf
 
Call Girls Pune Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Pune Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Pune Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Pune Just Call 9907093804 Top Class Call Girl Service Available
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
 
Best VIP Call Girls Noida Sector 40 Call Me: 8448380779
Best VIP Call Girls Noida Sector 40 Call Me: 8448380779Best VIP Call Girls Noida Sector 40 Call Me: 8448380779
Best VIP Call Girls Noida Sector 40 Call Me: 8448380779
 
Regression analysis: Simple Linear Regression Multiple Linear Regression
Regression analysis:  Simple Linear Regression Multiple Linear RegressionRegression analysis:  Simple Linear Regression Multiple Linear Regression
Regression analysis: Simple Linear Regression Multiple Linear Regression
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
 
Call Girls in Gomti Nagar - 7388211116 - With room Service
Call Girls in Gomti Nagar - 7388211116  - With room ServiceCall Girls in Gomti Nagar - 7388211116  - With room Service
Call Girls in Gomti Nagar - 7388211116 - With room Service
 

Joint Working workshop

  • 1. Joint Working Workshop The “7 Step framework” Sharing best practice Identifying opportunities using real world data Kevin Blakemore, National Partnership Manager| ABPI Helen Wheeler, National Project Manager | Sanofi Hassan Chaudhury, Director of Health Intelligence | Health iQ
  • 3. Quick Start Guide – May 2012
  • 5. Promotion Joint Working MEGS Sponsorship For patient benefit Yes Yes Yes Yes NHS/Pharma company pool resources X Yes X X Pharma company investment Yes Yes Yes Yes NHS investment X Yes X O Detailed agreement in place X Yes X X Shared commitment to successful delivery X Yes Yes Yes Details of the agreement are made public X Yes O X Prospective ROI Yes Yes X X Outcomes must be measured X Yes O X
  • 6. The Charles Town Project- Having the confidence to share gives us confidence to learn Helen Wheeler, National Project Manager | Sanofi
  • 7. Original Proposal •Aim was to form a collaborative group to undertake a programme of activities developed to address the health issues around Diabetes •To be known collectively as the “NHS Charles Town and Industry Maximising Resources and Outcomes in Diabetes (Concord )”project Goals •To ensure delivery of high quality diabetes care •To reduce diabetes health inequalities •Improve outcomes for all patients with diabetes in Charles Town regardless of where they live.
  • 8. Objectives of the Project 1) To reduce the rate / number of avoidable admissions to hospital for patients with diabetes and diabetes related illness. 2) To reduce the rate of inappropriate / avoidable utilisation of emergency services for people with diabetes related illnesses. 3) To develop and implement a coherent care planning approach to the management of people with diabetes across primary, secondary and community services, which ensures that all patients have the opportunity to be actively involved in decisions about how their diabetes is managed. 4) To work in partnership with all stakeholders including the pharmaceutical industry, in an innovative and inclusive way throughout the project to achieve outcomes which benefit patients with diabetes in Charles Town 5) To ensure that all activities are developed and implemented in a way which improves the quality, efficiency and cost effectiveness of care in line with national QIPP objectives.
  • 9. Primary Care Clinician /Secondary Care Clinician Primary Care Nurse (with diabetes expertise) Community Pharmacy/PBC cluster managers and clinical leads Charles Town “City Health” (provider arm) /NHS Charles Town Health promotion NHS Charles Town Public Health/ NHS Charles Town Clinical Audit/ NHS Charles Town Commissioning Directorate Pharmaceutical Industry (one seat per organisation) NHS Charles Town Primary Care Contracting/ NHS Charles Town Medicines Management + 8 industry partners Patient Representative Developed and managed in partnership with the ABPI Outreach Project who formed a group of interested member companies to act as equal stakeholders throughout. PCT-led project managed by a multi-professional multi-agency steering group consisting of a lead from each of the following stakeholder groups: Project Methodology
  • 10. In a Nutshell • In-Patient Audit commissioned by the LOCAL IMPLEMENTATION GROUP • Driven through a PROJECT GROUP • Managed by a highly experienced independent PROJECT MANAGER paid by the Project sponsors through the budget.
  • 11. Different stakeholders theoretically agreed with the project aims and rationale Equity of industry and NHS Endorsement of the Project from a high level (Chief Executive) Collaborative concept was good Excellent launch - with motivational and national figures in support Innovation project based upon a well established and successful project that the Project Manager had led previously In theory should have just replicated the last CHD project PM was a third party and theoretically objective and skilled What worked well
  • 12. Became a duel between commissioning lead/clinical leads and project lead Scepticism between NHS and industry had not left the room Industry was diluted - too many partners Skill set in the project team not utilised Industry had much of the data that was needed Level of investment did not = level of voice Project lead became a facilitator between Industry & NHS - should have been left behind once partnership agreed Poor dynamics Too controlled and inhibited freedom of speech Declaration of interest to other industry outside of the group Did the Project team fully understand the therapy area? No clear timelines What did not go so well
  • 13. What went wrong: key Communication between Stakeholders No real Equity of Voice
  • 14. Outcomes Questions were asked around: – Freedom of entry - became a closed shop – Competition Law – Lack of transparency due to communication between the PM and the LIG – Industry skill set not maximised/ Project Management experience – Loss of confidence by the LIG – LIG pulled out money - returned to industry
  • 15. What needs to happen – The Patient must be at the centre of all this otherwise what is it all about? – Old ways need to be left behind – innovation trust need to be our future honesty – Some one needs to step up and say: “Is this project going to lead to better Health outcomes for the Patient?” if the answer is yes “Have we as potential partners got the right resource and capacity together to drive this through”? if the answer is yes “well let‟s just get on with it”
  • 16. Where are we now? • LIG still see the Value in the Project • DUK still see value in the project • Industry has much of the data that is needed as well as the skill set and capacity to project manage • Access still difficult between Secondary Care and Industry • SC still very dominant and protective - this needs to change • Patients still in the same place and could be better serviced- no body won and the war keeps raging
  • 17. Ensure a mechanism for genuine input Use a more effective channel of communication to the LIG Improve the equity of voice - but perhaps less voices?? Have clear terms of references Better governance Make a safe environment for all stakeholders to give an honest declaration of interest - what do you want out of the project? - how as a company are you going to measure success? Ensure that the project is not dominated Identify and utilise what you already have before buying more Trust - do not move forward without this How would we do this differently?
  • 19. Group Work 1. How could some of these issues have been avoided? Refer to hand-out 2. How could the “7 Step framework” have been used? 3. Have you participated in a joint working project that was unsuccessful? a. why was it unsuccessful? b. what did you learn from it? 4. Of the 9 indicators for joint working, which are top 3 most important and why? a. Are there any other indicators that should be included ? Knowledge & Expertise Trust Ethics Project management Transparency Openness Respect Effectiveness Support
  • 20. Identifying Joint Working Opportunities- 7d Using real world data Hassan Chaudhury, Director of Health Intelligence | Health iQ
  • 21. CCG Data Quick Facts: – Not in London (somewhere in the Midlands) – Ethnically diverse. – Population of 600,000 - which is rapidly rising. – Over 50 GP Practices. – Higher than average deprivation. – Lower than average life expectancy with a lot of variation across the CCG. – Prescribing costs have gone up faster than expected as have emergency admissions. – Mental health costs are very high. • It has had discussions on choosing its 3 local measures for the Quality Premium (c.f. http://www.england.nhs.uk/wp-content/uploads/2013/05/qual-premium.pdf)
  • 22. What is the Quality Premium? Four Areas to explain: 1.The „quality premium‟ is intended to reward clinical commissioning groups (CCGs) for improvements in the quality of the services that they commission and for associated improvements in health outcomes and reducing inequalities. 2.The quality premium paid to CCGs in 2014/15 – to reflect the quality of the health services commissioned by them in 2013/14 – will be based on: four national measures and three local measures.
  • 23. What is the Quality Premium? 3. The four national measures, all of which are based on measures in the NHS Outcomes Framework, are: 1) reducing potential years of lives lost through amenable mortality (12.5 per cent of quality premium): the overarching objective for Domain 1 of the NHS Outcomes Framework; 2) reducing avoidable emergency admissions (25 per cent of quality premium): a composite measure drawn from four measures in Domains 2 and 3 of the NHS Outcomes Framework; 3) ensuring roll-out of the Friends and Family Test and improving patient experience of hospital services (12.5 per cent of quality premium), based on one of the overarching objectives for Domain 4 of the NHS Outcomes Framework 4) preventing healthcare associated infections (12.5 per cent of quality premium), based on one of the objectives for Domain 5 of the NHS Outcomes Framework.
  • 24. What is the Quality Premium? 4. The three local measures should be based on local priorities such as those identified in joint health and wellbeing strategies. These will be agreed by individual CCGs with their Health and Wellbeing Boards and with the area teams of the NHS Commissioning Board (NHS CB). What they select must also be in line with other local priorities e.g.: - Improved Outcomes - High Quality Care - Tackle unwarranted variation and strengthen out of hospital care - Efficient and effective care pathways - Development of integrated multi agency care pathways
  • 25. What is the Quality Premium? It was decided that the three local measures would be selected to also help achieve the four national measures. The most significant of the national measures is on emergency admissions (25% of the total). - Last year there were over 56,000 emergency admissions of local residents. - Giving a rate of 75 admissions per 1,000 people. - Of these admissions over 25,400 (44%) are repeat emergency admissions. - Over a half of all emergency admissions arrive via the hospital‟s A&E department. - Nearly a third of admissions arrive from a General Practitioner (GP) These two methods account for nearly 90% of all emergency admissions. - The total cost of all emergency admissions by local residents exceeded £90 million.
  • 26. Group Work Look at the following data on emergency admissions and decide: what does the data demonstrate? Can you use this information to select areas for your local measure or is further information required? If so, which areas would you want to focus on and what you would want to achieve? 15 Minutes
  • 27. Local Measures The 3 areas they chose were CHD, COPD and Diabetes. ACSC emergency admissions in the CCG now make up 14.1% of all emergency hospital admissions, at a current cost of around £13 million annually. This is what they wanted to achieve: 1. Increasing the number of patients with coronary heart disease who completed cardiac rehabilitation. 2. Increasing the number of people with COPD referred to a pulmonary rehabilitation programme. 3. Increasing the number of people with diabetes diagnosed less than a year being referred to structured education.
  • 28. Let’s focus on diabetes… • What Joint Working opportunities can you think of? • How can parties work together for the benefit of patients, industry and the NHS? • How would you utilise the 7 step framework? • Would you help with setting up a Diabetes Multidisciplinary Team (NDMT) i.e. a group of specialist nurses, podiatrists, dieticians, diabetologists, and multi-skilled practitioners: all dedicated to improving the quality of care and providing people with diabetes with the training needed to help them self-manage • Would you help with data? • Patient support? Perhaps help to map pathways. The choice is yours 15 Minutes
  • 29. Closing Remarks7d Outcomes and Feedback Karen Thomas, Regional Partnership Manager London | ABPI
  • 30. What do you see?
  • 32. To achieve……. “ High quality care for all, for now and for the future generations” NHS England